title: Use of interleukin-11 after autologous stem cell transplant: report of three cases and a very brief review of the literature.
authors.forename: J R
authors.initials: JR
authors.lastname: Borbolla
authors.forename: M A
authors.initials: MA
authors.lastname: López-Hernández
authors.forename: J
authors.initials: J
authors.lastname: De Diego
authors.forename: M
authors.initials: M
authors.lastname: González-Avante
authors.forename: E
authors.initials: E
authors.lastname: Trueba
authors.forename: M T
authors.initials: MT
authors.lastname: Collados
mesh_terms: D000328:Adult; D001792:Blood Platelets / Q000166:cytology / Q000187:drug effects; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D017370:Interleukin-11 / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage*; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D014182:Transplantation, Autologous / Q000009:adverse effects
chemical_list: D017370:Interleukin-11; D011994:Recombinant Proteins; C105308:oprelvekin